Abbott Laboratories vs. Generate Biomedicines, Inc. Common Stock
ABT
Abbott Laboratories
$106.20 +1.56%
VS GENBGenerate Biomedicines, Inc. Common Stock
$14.46 -8.31%
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | GENB | |
|---|---|---|
| Market Cap | $183.77 billion | $1.86 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | GENB | |
|---|---|---|
| Dividend Yield | 2.37% | — |
ABT and GENB split the dividend factors evenly.
Risk & Sentiment
| ABT | GENB | |
|---|---|---|
| Short Interest | 0.57% | 0.70% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, GENB overview, GENB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.